CD34 is a drug target for AML and CML
Ontology highlight
ABSTRACT: EGFR inhibitors selectively kill CD34+ leukemia cells and induced clinical remission in patients with high percentage of CD34+ blast
ORGANISM(S): Homo Sapiens
SUBMITTER: Ying Lu
PROVIDER: PXD023328 | iProX | Wed Dec 30 00:00:00 GMT 2020
REPOSITORIES: iProX
ACCESS DATA